- Issuer ticker
-
CSTL
- Reported as of
-
10 Jun 2021
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
14 Jun 2021, 16:34:14 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Greg Acosta, Attorney-in-fact
Key filing fact
KABAKOFF DAVID S filed Form 4 for CASTLE BIOSCIENCES INC (CSTL) on 14 Jun 2021.
Key facts
- This page summarizes KABAKOFF DAVID S's Form 4 filing for CASTLE BIOSCIENCES INC (CSTL).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 14 Jun 2021, 16:34.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CSTL
transaction
Derivative
Stock option (right to buy)
Award
- Transaction value
- $0
- Shares
- +3,379
- Change %
- Price
-
$0.000000
- Shares after
- 3,379
- Date
- 10 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,379
- Exercise price
- $71.22
CSTL
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +830
- Change %
- Price
-
$0.000000
- Shares after
- 830
- Date
- 10 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 830
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes